Ligand validation:3VHH

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3VHH designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VHH_NAG_D_1125	53%	19%	0.142	0.901	1.33	2.11	3	4	3	0	100%	0.9333
3VHH_NAG_A_1125	49%	28%	0.171	0.917	1.39	1.48	2	2	2	0	100%	0.9333
3VHH_NAG_B_1125	43%	16%	0.17	0.894	1.67	2.04	3	5	0	0	100%	0.9333
3VHH_NAG_C_1125	39%	13%	0.206	0.913	1.48	2.48	2	3	1	0	100%	0.9333
5IRW_NAG_A_201	72%	56%	0.116	0.94	0.8	0.91	-	-	1	0	100%	0.9333
3VHM_NAG_D_1125	71%	14%	0.107	0.928	1.38	2.42	2	3	5	0	100%	0.9333
5IRU_NAG_A_201	71%	64%	0.115	0.934	0.71	0.68	-	-	0	0	100%	0.9333
5MYQ_NAG_A_302	65%	28%	0.111	0.913	0.82	2.05	-	1	0	0	100%	0.9333
3VGW_NAG_B_1125	51%	5%	0.146	0.899	1.64	3.76	1	8	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.